29 results
P
lung disease, li, ipf
I/C
baicalin, no intervention
O
reduced inflammation, decreased apoptosis, protected against progression
P
non-ICU patients
I/C
acid-suppressive medications, placebos (gastric mucosa protectants), H2-receptor antagonists, proton pump inhibitors (PPIs)
O
occurrence of SU bleeding, adverse drug events (ADEs)
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
Li QL, Yao MF, Cao RY, Zhao K, Wang XD
I/C
short dental implants, splinted and nonsplinted prostheses
O
survival rates
P
adult population, over 60 years old, under 18 years old
I/C
reminder sent by mail
O
adherence to influenza vaccination
P
Individuals participating in blood flow restriction (BFR) training
I/C
BFR training, High-intensity resistance training (HIRT)
O
Muscular strength, hypertrophy, and endurance
P
red yeast rice preparations
I/C
RYR preparations, control treatments
O
adverse health outcomes
P
fractures involving the posterior malleolus (PM) of the ankle
I/C
cannulated screws versus plate with screw fixation, no statistically significant difference in the development of postoperative ankle osteoarthritis and functional outcomes
O
no significant difference in the development of postoperative ankle osteoarthritis and functional outcomes
P
soggetti esposti professionalmente a glifosato
I/C
esposizione professionale a glifosato, soggetti non esposti a glifosato
O
rischio di linfoma non Hodgkin (NHL) e mieloma multiplo (MM)
P
older adults without cognitive impairment
I/C
anticholinergic medications, cognitive decline or dementia
O
risk of cognitive decline or dementia